Primary Endpoints | |
• T cell subsets: - CD4 and CD8 positive T cells: naïve T cells, T effector cells, T memory cells, regulatory T cells - T-helper subsets: Th1, Th2, Th17 | |
• B cell subsets: - Recent bone marrow emigrants, mature naïve, memory B cells - Plasma cells | |
• Natural killer cells: - CD56bright, CD56dim - Natural killer T cells | |
• Antigen-presenting cells: - Dendritic cells: CD303+ plasmacytoid, CD11c+ and CD141+ myeloid dendritic cells - Monocytes and macrophages | |
• Myeloid-derived suppressor cells | |
• Markers of autoimmunity in the serum (every 6 months): - ANA, cANCA, pANCA, anti-dsDNA, anti-TSHR, anti-TPO, RF, anti-CCP, anti-GBM, anti-platelet antibodies | |
Secondary Endpoints | |
• Activation status of cell surface receptors assessed by flow cytometry: - Relative and absolute change from baseline of mean fluorescence intensity (MFI) and the proportion of positive cells regarding CD25, HLA-DR, LFA-1, CD29, CD69, CD71 expression | |
• Expression of co-inhibitory molecules assessed by flow cytometry: - Relative and absolute change from baseline of MFI and of the proportion of positive cells regarding PD-1 = CD279, ICOS = CD278, TIM-3, CTLA4 expression | |
• Effector functions of CD4 and CD8 positive T cells: - Relative and absolute change from baseline of the results of cell proliferation assays assessed as the percentage of proliferated cells - Relative and absolute change from baseline of cytokine production measurement assessed as concentration - Relative and absolute change from baseline of the cytolytic activity assessed by flow cytometry measurement of MFI and proportion of positive cells regarding Granzyme B, Perforin and CD107a expression - Relative and absolute change from baseline of intracellular calcium response assessed as a ratio | |
• Migrational capacity: - Relative and absolute change from baseline MFI and the proportion of positive cells assessed by flow cytometry expression analysis of CD11a, CD31, CD44, CD49d, CCR5, CCR6, CCR7 - Absolute and relative change of cell numbers of migrated cells compared to baseline assessed in an in vitro model by flow cytometry analysis | |
• High-throughput TCR- and BCR sequencing of the T- and B cell rep-ertoire concerning the expansion of distinct clones: - Qualitative comparison of the distribution of CDR3 sequences | |
• Regulatory T-cell function: - Relative and absolute change from baseline in production of TGF-beta and IL-10 of CD4+CD25+FOXP3+ regulatory T cells - Suppression of T cell proliferation: Relative and absolute change from baseline in responder T cell proliferation assessed by suppression assays |